Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.50p
   
  • Change Today:
      0.95p
  • 52 Week High: 12.00
  • 52 Week Low: 6.55
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 4,654,914
  • Market Cap: £57.50m

Latest ShareCast News

Poolbeg Pharma to be granted US patent

By Josh White

Date: Wednesday 20 Mar 2024

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has received a notice of allowance from the US Patent Office regarding its immunomodulator II patent application.

Director dealings: Poolbeg Pharma co-founder ups stake

By Iain Gilbert

Date: Monday 19 Feb 2024

(Sharecast News) - Poolbeg Pharma revealed on Monday that chairman Cathal Friel had acquired 830,000 ordinary shares in the AIM-listed biopharmaceutical company.

Poolbeg upbeat on research into potential drug market

By Josh White

Date: Monday 12 Feb 2024

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced findings from independent research confirming a substantial market opportunity exceeding $10bn for its drug candidate POLB 001 on Monday, in preventing cancer immunotherapy-induced cytokine release syndrome (CRS) through oral delivery.

Poolbeg makes promising progress with RSV progra... 20-Dec-2023 ShareCast
Poolbeg gets notice of a new Japan patent 20-Sep-2023 ShareCast
Poolbeg reports progress with oral vaccine devel... 22-Jun-2023 ShareCast
Poolbeg expands its focus molecule into oncology 16-Jan-2023 ShareCast
Poolbeg identifies new drug candidates with OneT... 21-Dec-2022 ShareCast
Poolbeg secures exclusive licence to possible ob... 14-Dec-2022 ShareCast
Poolbeg announces 'breakthrough' in AI drug targ... 08-Nov-2022 ShareCast
Poolbeg Pharma upbeat on US patent application p... 04-Oct-2022 ShareCast
Poolbeg inks exclusive deal for melioidosis vacc... 21-Sep-2022 ShareCast
Poolbeg granted European patent for antiviral no... 14-Apr-2022 ShareCast
Poolbeg signs option deal for potential melioido... 06-Dec-2021 ShareCast
Poolbeg adds Daniel Hoft to scientific advisory ... 25-Nov-2021 ShareCast
New patents filed to protect Poolbeg disease pre... 14-Oct-2021 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 11.50p
Change Today 0.95p
% Change 9.00 %
52 Week High 12.00
52 Week Low 6.55
Volume 4,654,914
Shares Issued 500.00m
Market Cap £57.50m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.24% below the market average60.24% below the market average60.24% below the market average60.24% below the market average60.24% below the market average
43.4% below the sector average43.4% below the sector average43.4% below the sector average43.4% below the sector average43.4% below the sector average
Price Trend
94.50% above the market average94.50% above the market average94.50% above the market average94.50% above the market average94.50% above the market average
96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
12:29 950,000 @ 11.90p
17:06 257,000 @ 11.50p
16:30 16,238 @ 11.36p
16:23 22,220 @ 11.50p
16:22 233 @ 11.50p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page